Divergent biological effects of estradiol and diethylstilbestrol in the prostate cancer cell line MOP

Journal of Steroid Biochemistry and Molecular Biology

Volumn 96, Issue 2, 2005, Pages 119-129

  Kalach, Jean Jacques ^a   Joly Pharaboz, Marie Odile ^b,d   Chantepie, Jacqueline ^a   Nicolas, Brigitte ^d   Descotes, Françoise ^c   Mauduit, Claire ^a   Benahmed, Mohamed ^a   André, Jean ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d DTAM   (France)

Author keywords

Androgen resistance; Bicalutamide; Cell proliferation; Estradiol; Hormone relapsed; Inhibition; Prostate cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; BICALUTAMIDE; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GROWTH INHIBITION; HORMONE BINDING; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN FUNCTION; RECEPTOR BINDING; TRANSCRIPTION INITIATION; UPREGULATION;

CELL DIVISION; CELL LINE, TUMOR; DIETHYLSTILBESTROL; ESTRADIOL; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 23244449732     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.02.012     Document Type: Article

References (60)

1. J.M. Kokontis, and S. Liao Molecular action of androgen in the normal and neoplastic prostate Vitam. Horm. 55 1999 219 307
2. J.T. Isaacs Role of androgens in prostatic cancer Vitam. Horm. 49 1994 433 502
3. S.R. Denmeade, and J.T. Isaacs Development of prostate cancer treatment: the good news Prostate 58 3 2004 211 224
4. E.D. Crawford, E.P. Deantonio, F. Labrie, F.H. Schroder, and J. Geller Endocrine therapy of prostate cancer: optimal form and appropriate timing J. Clin. Endocrinol. Metab. 80 4 1995 1062 1066
5. A.M. DeMarzo, W.G. Nelson, W.B. Isaacs, and J.I. Epstein Pathological and molecular aspects of prostate cancer Lancet 361 9361 2003 955 964
6. J.T. Arnold, and J.T. Isaacs Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault Endocr. Relat. Cancer 9 1 2002 61 73
7. C.D. Chen, D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, and C.L. Sawyers Molecular determinants of resistance to antiandrogen therapy Nat. Med. 10 1 2004 33 39
8. B.J. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 1 2001 34 45
9. M.O. Joly-Pharaboz, M.C. Soave, B. Nicolas, F. Mebarki, M. Renaud, O. Foury, Y. Morel, and J.G. Andre Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP J. Steroid Biochem. Mol. Biol. 55 1 1995 67 76
10. Y. Umekita, R.A. Hiipakka, J.M. Kokontis, and S. Liao Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride Proc. Natl. Acad. Sci. U.S.A. 93 21 1996 11802 11807
11. M.-O. Joly-Pharaboz, A. Ruffion, A.-M. Roch, L. Michel-Calemard, J. Chantepie, B. Nicolas, and J. Andre Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line J. Steroid Biochem. Mol. Biol. 73 5 2000 237 249
12. M. Hasenson, B. Hartley-Asp, C. Kihlfors, A. Lundin, J.A. Gustafsson, and A. Pousette Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r Prostate 7 2 1985 183 194
13. H.Y. Zhau, S.M. Chang, B.Q. Chen, Y. Wang, H. Zhang, C. Kao, Q.A. Sang, S.J. Pathak, and L.W. Chung Androgen-repressed phenotype in human prostate cancer Proc. Natl. Acad. Sci. U.S.A. 93 26 1996 15152 15157
14. J. Veldscholte, C. Ris-Stalpers, G.G. Kuiper, G. Jenster, C. Berrevoets, E. Claassen, H.C. van Rooij, J. Trapman, A.O. Brinkmann, and E. Mulder A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens Biochem. Biophys. Res. Commun. 173 2 1990 534 540
15. C. Huggins, and C. Hodges The effect of castration, of estrogen and androgen injection on serum phosphatase in metastatic carcinoma of the prostate Cancer Res. 1 1941 293 297
16. D.S. Scherr, and W.R. Pitts Jr. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer J. Urol. 170 5 2003 1703 1708
17. S.M. Ho Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates J. Cell. Biochem. 91 3 2004 491 503
18. M.C. Bosland The role of steroid hormones in prostate carcinogenesis J. Natl. Cancer Inst. Monogr. 27 2000 39 66
19. G.S. Prinsac, L. Birch, H. Habermann, W.Y. Chang, C. Tebeau, O. Putz, and C. Bieberich Influence of neonatal estrogens on rat prostate development Reprod. Fertil. Dev. 13 4 2001 241 252
20. G. Risbridger, H. Wang, P. Young, T. Kurita, Y.Z. Wang, D. Lubahn, J.A. Gustafsson, G. Cunha, and Y.Z. Wong Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium Dev. Biol. 229 2 2001 432 442
21. B. Jin, L. Turner, W.A. Walters, and D.J. Handelsman The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected] J. Clin. Endocrinol. Metab. 81 12 1996 4290 4295
22. G.P. Risbridger, J.J. Bianco, S.J. Ellem, and S.J. McPherson Oestrogens and prostate cancer Endocr. Relat. Cancer 10 2 2003 187 191
23. S. Mosselman, J. Polman, and R. Dijkema ER beta: identification and characterization of a novel human estrogen receptor FEBS Lett. 392 1 1996 49 53
24. E. Enmark, M. Pelto-Huikko, K. Grandien, S. Lagercrantz, J. Lagercrantz, G. Fried, M. Nordenskjold, and J.A. Gustafsson Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern J. Clin. Endocrinol. Metab. 82 12 1997 4258 4265
25. G. Wilding, M. Chen, and E.P. Gelmann Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens Prostate 14 2 1989 103 115
26. N. Olea, K. Sakabe, A.M. Soto, and C. Sonnenschein The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP Endocrinology 126 3 1990 1457 1463
27. C. Lee, D.M. Sutkowski, J.A. Sensibar, D. Zelner, I. Kim, I. Amsel, N. Shaw, G.S. Prins, and J.M. Kozlowski Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone Endocrinology 136 2 1995 796 803
28. E. Corey, J.E. Quinn, M.J. Emond, K.R. Buhler, L.G. Brown, and R.L. Vessella Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol Clin. Cancer Res. 8 4 2002 1003 1007
29. G. Carruba, U. Pfeffer, E. Fecarotta, D.A. Coviello, E. D'Amato, M. Lo Castro, G. Vidali, and L. Castagnetta Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells Cancer Res. 54 5 1994 1190 1193
30. K.M. Lau, M. LaSpina, J. Long, and S.M. Ho Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation Cancer Res. 60 12 2000 3175 3182
31. T.M. LaVallee, X.H. Zhan, C.J. Herbstritt, E.C. Kough, S.J. Green, and V.S. Pribluda 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta Cancer Res. 62 13 2002 3691 3697
32. I.Y. Kim, H. Seong do, B.C. Kim, D.K. Lee, A.T. Remaley, F. Leach, R.A. Morton, and S.J. Kim Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway Cancer Res. 62 13 2002 3649 3653
33. I.Y. Kim, B.C. Kim, H. Seong do, D.K. Lee, J.M. Seo, Y.J. Hong, H.T. Kim, R.A. Morton, and S.J. Kim Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines Cancer Res. 62 18 2002 5365 5369
34. L.A. Castagnetta, M.D. Miceli, C.M. Sorci, U. Pfeffer, R. Farruggio, G. Oliveri, M. Calabro, and G. Carruba Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor Endocrinology 136 5 1995 2309 2319
35. A. Migliaccio, G. Castoria, M. Di Domenico, A. de Falco, A. Bilancio, M. Lombardi, M.V. Barone, D. Ametrano, M.S. Zannini, C. Abbondanza, and F. Auricchio Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation Embo. J. 19 20 2000 5406 5417
36. M. Maggiolini, A.G. Recchia, A. Carpino, A. Vivacqua, G. Fasanella, V. Rago, V. Pezzi, P.A. Briand, D. Picard, and S. Ando Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells J. Mol. Endocrinol. 32 3 2004 777 791
37. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.A. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 10 1998 4252 4263
38. A. Joyeux, P. Balaguer, P. Germain, A.M. Boussioux, M. Pons, and J.C. Nicolas Engineered cell lines as a tool for monitoring biological activity of hormone analogs Anal. Biochem. 249 2 1997 119 130
39. V.E. Quarmby, W.G. Yarbrough, D.B. Lubahn, F.S. French, and E.M. Wilson Autologous down-regulation of androgen receptor messenger ribonucleic acid Mol. Endocrinol. 4 1 1990 22 28
40. J. Trapman, C. Ris-Stalpers, J.A. van der Korput, G.G. Kuiper, P.W. Faber, J.C. Romijn, E. Mulder, and A.O. Brinkmann The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines J. Steroid Biochem. Mol. Biol. 37 6 1990 837 842
41. B.T. Montgomery, C.Y. Young, D.L. Bilhartz, P.E. Andrews, J.L. Prescott, N.F. Thompson, and D.J. Tindall Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP Prostate 21 1 1992 63 73
42. D. Bigler, K.M. Gulding, R. Dann, F.Z. Sheabar, M.R. Conaway, and D. Theodorescu Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action Oncogene 22 8 2003 1261 1272
43. P. Schulz, H.W. Bauer, W.P. Brade, A. Keller, and F. Fittler Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells Cancer Res. 48 10 1988 2867 2870
44. C.N. Robertson, K.M. Roberson, G.M. Padilla, E.T. O'Brien, J.M. Cook, C.S. Kim, and R.L. Fine Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells J. Natl. Cancer Inst. 88 13 1996 908 917
45. S. Yeh, H. Miyamoto, H. Shima, and C. Chang From estrogen to androgen receptor: a new pathway for sex hormones in prostate Proc. Natl. Acad. Sci. U.S.A. 95 10 1998 5527 5532
46. C.P. Cheung, S. Yu, K.B. Wong, L.W. Chan, F.M. Lai, X. Wang, M. Suetsugi, S. Chen, and F.L. Chan Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues J. Clin. Endocrinol. Metab. 2004
47. H. Greschik, R. Flaig, J.P. Renaud, and D. Moras Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity J. Biol. Chem. 279 32 2004 33639 33646
48. S. Hirata, T. Shoda, J. Kato, and K. Hoshi Isoform/variant mRNAs for sex steroid hormone receptors in humans Trends Endocrinol. Metab. 14 3 2003 124 129
49. L.A. Castagnetta, G. Carruba, Human prostate cancer: a direct role for oestrogens, Ciba Found Symp. 191 (1995) 269-286; discussion 286-289.
50. A. Migliaccio, G. Castoria, M. Di Domenico, A. De Falco, A. Bilancio, and F. Auricchio Src is an initial target of sex steroid hormone action Ann. NY Acad. Sci. 963 2002 185 190
51. I.G. Schulman, C. Li, J.W. Schwabe, and R.M. Evans The phantom ligand effect: allosteric control of transcription by the retinoid × receptor Genes Dev. 11 3 1997 299 308
52. Z. Culig, A. Hobisch, M.V. Cronauer, A.C. Cato, A. Hittmair, C. Radmayr, J. Eberle, G. Bartsch, and H. Klocker Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone Mol. Endocrinol. 7 12 1993 1541 1550
53. Z. Weihua, S. Andersson, G. Cheng, E.R. Simpson, M. Warner, and J.A. Gustafsson Update on estrogen signaling FEBS Lett. 546 1 2003 17 24
54. A. Latil, I. Bieche, D. Vidaud, R. Lidereau, P. Berthon, O. Cussenot, and M. Vidaud Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res. 61 5 2001 1919 1926
55. L.G. Horvath, S.M. Henshall, C.S. Lee, D.R. Head, D.I. Quinn, S. Makela, W. Delprado, D. Golovsky, P.C. Brenner, G. O'Neill, R. Kooner, P.D. Stricker, J.J. Grygiel, J.A. Gustafsson, and R.L. Sutherland Frequent loss of estrogen receptor-beta expression in prostate cancer Cancer Res. 61 14 2001 5331 5335
56. J.L. Ockrim, E.N. Lalani, M.E. Laniado, S.S. Carter, and P.D. Abel Transdermal estradiol therapy for advanced prostate cancer - forward to the past? J. Urol. 169 5 2003 1735 1737
57. T.L. Tinley, R.M. Leal, D.A. Randall-Hlubek, J.W. Cessac, L.R. Wilkens, P.N. Rao, and S.L. Mooberry Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res. 63 7 2003 1538 1549
58. B.L. Neubauer, A.M. McNulty, M. Chedid, K. Chen, R.L. Goode, M.A. Johnson, C.D. Jones, V. Krishnan, R. Lynch, H.E. Osborne, and J.R. Graff The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model Cancer Res. 63 18 2003 6056 6062
59. T.M. LaVallee, X.H. Zhan, M.S. Johnson, C.J. Herbstritt, G. Swartz, M.S. Williams, W.A. Hembrough, S.J. Green, and V.S. Pribluda 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway Cancer Res. 63 2 2003 468 475
60. K. Shimada, M. Nakamura, E. Ishida, M. Kishi, S. Matsuyoshi, and N. Konishi The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells Mol. Carcinog. 39 1 2004 1 9